Historique de carrière de Marc E. Uknis
Anciens postes connus de Marc E. Uknis
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GEMI THER | Directeur Technique/Scientifique/R&D | 01/03/2020 | 11/04/2021 |
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2018 | 28/01/2020 |
Formation de Marc E. Uknis
| George Washington University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Masters Business Admin | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Gemini Therapeutics, Inc.
 Gemini Therapeutics, Inc. BiotechnologyHealth Technology Gemini Therapeutics, Inc. is a clinical-stage precision medicine company. It is developing novel therapeutic compounds to treat genetically defined, age-related macular degeneration. The company was founded by Johanna Seddon, Paul Barlow and Andrew Herbert on March 3, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Marc E. Uknis
- Expérience
